Home Emisphere Launches Eligen B12a , the First Oral Prescription Tablet...
 

Keywords :   


Emisphere Launches Eligen B12a , the First Oral Prescription Tablet...

2015-03-19 14:20:38| Biotech - Topix.net

Eligen B12 is indicated for the dietary management of patients who have a medically-diagnosed vitamin B12 deficiency, associated with a disease or condition that cannot be managed by a modification of the normal diet alone. Technology, which utilizes a carrier, salcaprozate sodium or SNAC, to chaperone B12 through the gastric lining and directly into the bloodstream independent of intrinsic factor, a protein made in the stomach that normally facilitates B12 absorption.

Tags: oral prescription launches tablet

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
21.05Estée Lauder Companies Presents Research at the Society for Investigative Dermatology Annual ...
21.05Dove Launches Whole Body Deodorants for 72-Hour Odor Protection
21.05Drowsy Sleep Co Launches Eyelash Protecting Mask
21.05Growth Opportunities in Upcycled Ingredients Anticipated Through 2032
21.05Superior Environmental Solutions Acquires Arrowhead Environmental Services
21.05Kinderhook Partners with Apex Waste Solutions and Acquires Materials Management Company and All American Disposal
21.05Liebherr Appoints Hobgood as New GM of Corporate Responsibility and Sustainability
21.05Tennessee Recycling Center Closing Due to Continued Dumping of Un-Recyclable Materials
More »